The Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Obese Children and Adolescents in Dalmatia: A Hospital Based Study

Table 2

Biochemical and clinical characteristics of subjects enrolled in the study.

Parameter	Moderately obese ()	Severely obese ()
Acanthosis, (%)	52 (47.3)	54 (59.3)	0.088
Total cholesterol (mmol/L)	4.37 ± 0.88^†	4.44 ± 0.75	0.519
Triglycerides (mmol/L)	1.37 ± 0.75	1.42 ± 0.70	0.653
HDL (mmol/L)	1.27 ± 0.41	1.24 ± 0.31	0.610
LDL^† (mmol/L)	2.46 ± 0.83	2.52 ± 0.70	0.628
Fasting glucose (mmol/L)	4.86 ± 0.55	4.79 ± 0.51	0.402
Glucose 120 min (mmol/L)	6.14 ± 1.15	6.11 ± 1.28	0.871
Fasting insulin (mIU/L)	19.97 ± 13.71	24.28 ± 15.01	0.037
Insulin 120 min (mIU/L)	77.18 ± 75.50	86.74 ± 72.34	0.364
HOMA-IR^‡	4.35 ± 3.22	5.21 ± 3.21	0.063
ISI	3.61 ± 2.37	3.09 ± 2.76	0.163
SBP^‖ (mmHg)	124.50 ± 14.52	129.91 ± 16.96	0.018
DBP (mmHg)	78.78 ± 9.09	82.90 ± 10.45	0.004

HDL: high density lipoproteins, ^†LDL: low density lipoproteins, ^‡HOMA-IR: homeostatic model assessment insulin resistance, ISI: Matsuda index, ^‖SBP: systolic blood pressure, and DBP: diastolic blood pressure.